Weighing options: empiric antibiotic use and stewardship opportunities in critically ill patients with community-acquired pneumonia
In this retrospective study, critically ill patients with community-acquired pneumonia frequently received empiric anti-methicillin-resistant Staphylococcus aureus (MRSA) and antipseudomonal antibiotics despite having few or no guidelines-endorsed risk factors. De-escalation of anti-MRSA therapy was quicker, likely aided by MRSA polymerase chain reaction assays.
Authors
- Nalea Trujillo (ORCID: https://orcid.org/0009-0008-8624-5530)
- Marisa Holubar (ORCID: https://orcid.org/0000-0002-7585-1809)
- Ariadna Garcia (ORCID: https://orcid.org/0000-0001-6740-7081)
- Calvin Diep (ORCID: https://orcid.org/0000-0002-6238-2011)
- D. Ha
Institutions
- Stanford Health Care (US)
- Stanford Medicine (US)
- Stanford University (US)
Publication Details
- Journal
- Antimicrobial Stewardship & Healthcare Epidemiology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1017/ash.2025.10082
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00